No plans to scale back in Japan as AstraZeneca looks to "good quality" growth
This article was originally published in Scrip
Executive Summary
With several major new launches coming through and "a lot going on in our portfolio," AstraZeneca sees Japan as a key market and has no plans to reduce local headcount despite the restructuring elsewhere in the group, says the firm's new country president.